QiagenQGEN
13F holders, Q1 2026 (March 31)6holders −286
1new positions
66sold out
$40.06avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Qiagen N.V. (QGEN) in their 13F filings, down 286 from Q4 2025. 1 opened new positions and 66 sold out. The largest holders were Barclays PLC ($37.1M), Signaturefd, LLC ($108K) and Sankala Group LLC ($6K).
- Company
- Qiagen N.V.
- CUSIP
- N72482206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 66 | $132.5M |
All 13F filers, Q4 2025 → Q1 2026: 28 shares bought and 3,535,869 shares sold, net −3,535,841 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Barclays PLC | 0.01% | Reduce -39.8% | 926,808 | $37.1M |
| Signaturefd, LLC | 0.00% | Reduce -48.1% | 2,692 | $108K |
| Sankala Group LLC | 0.00% | No change | 152 | $6K |
| IFP Advisors, Inc | 0.00% | Reduce -13.5% | 77 | $4K |
| Investors Research Corp | 0.00% | New | 28 | $1K |
| Huntington National Bank | 0.00% | Reduce -99.7% | 1 | $47 |
"% of holder's portfolio" is QGEN's weight in each manager's 13F, not the share of Qiagen N.V. the manager owns.